RetCAT
Commercial- Indications
- Vision impairment, Diabetic retinopathy
Company intelligence / Profile preview
PROMinsight has developed and validated several computer-adaptive tests for measuring quality of life in patients with various eye conditions and diabetes. Their platform is used in clinical trials to efficiently collect high-quality patient-reported data. The technology reduces questionnaire burden by up to 70% compared to traditional methods and is currently enhancing data collection in ongoing clinical trials at major centers such as the Singapore National Eye Centre.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PROMinsight.